chevron_leftBack
As of 25 June 2026, Pharmosa Biopharm Inc. has a market cap of $154.45M USD, ranking #22647 globally and #1110 in Taiwan.
It ranks #2028 in the Healthcare sector, and #390 in the Biotechnology industry.
Key Stats
Market Cap
$154.45MUSD
4.91B TWD
Enterprise Value
$121.99MUSD
3.88B TWD
Revenue (TTM)
$2.12MUSD
67.27M TWD
EBITDA (TTM)
-$12.02MUSD
-382.04M TWD
Net Income (TTM)
-$12.08MUSD
-383.85M TWD
PS Ratio
73.0
PB Ratio
3.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Pei Kan
open_in_new
Employees
40
Founded
2000
Website
pharmosa.com.tw
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -2.6% | 1.4% | -4.8% | -18% | -32% | -27% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
6875
國邑藥品科技股份有限公司
ISIN: TW0006875008
Shares Out.:
Shares Outstanding:
129.183M1
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
37.00 TWD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Pharmosa Biopharm Inc.
Pharmosa Biopharm Inc., a biotechnology company, focuses on developing drugs in Taiwan. It develops L606, an inhalation/device combination for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; and L608, an inhalation/device combination for the treatment of pulmonary vascular disease. The company was formerly known as Pharmosa Limited and changed its name to Pharmosa Biopharm Inc. in October 2016. Pharmosa Biopharm Inc. was founded in 2000 and is headquartered in Taipei, Taiwan.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TWSE: 6919
|
$5.44B
3K%
172.76B TWD
|
-
|
|
TWSE: 6949
|
$1.6B
938%
50.93B TWD
|
-
|
|
TPEX: 6696
|
$1.07B
594%
34.04B TWD
|
-
|
|
TWSE: 7827
|
$702.95M
355%
22.34B TWD
|
-
|
|
|
TPEX: 7827
|
$597.34M
287%
18.98B TWD
|
-
|
|
TPEX: 06891
|
$568.49M
268%
18.06B TWD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: AMGN
|
$182.42B
118K%
|
23.9
|
|
NASDAQ: GILD
|
$159.92B
103K%
|
19.0
|
|
EBR: ARGX
|
$47.0B
30K%
41.39B EUR
|
39.9
|
|
KRX: 207940
|
$44.17B
28K%
68.19T KRW
|
35.5
|
|
ASX: CSL
|
$41.5B
27K%
60.27B AUD
|
29.3
|
|
SIX: LONN
|
$41.5B
27K%
33.71B CHF
|
37.2
|
chevron_leftBack